SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-369517
Filing Date
2017-12-14
Accepted
2017-12-14 16:25:03
Documents
3
Period of Report
2017-12-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d444395d8k.htm 8-K 14786
2 EX-99.1 d444395dex991.htm EX-99.1 44566
3 GRAPHIC g444395dsp04.jpg GRAPHIC 5747
  Complete submission text file 0001193125-17-369517.txt   68663
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 171256451
SIC: 2834 Pharmaceutical Preparations